These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11486553)

  • 21. [Comparative evaluation of the effectiveness of antibacterial therapeutic methods and agents in acute intestinal infections (a review of the literature)].
    Levitov TA
    Voen Med Zh; 1976; (5):38-43. PubMed ID: 785810
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal models.
    Schentag JJ; Meagher AK; Forrest A
    Ann Pharmacother; 2003 Sep; 37(9):1287-98. PubMed ID: 12921513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The choice of antimicrobial drugs.
    Med Lett Drugs Ther; 1984 Mar; 26(656):19-26. PubMed ID: 6700533
    [No Abstract]   [Full Text] [Related]  

  • 24. Quinolones in 2005: an update.
    Van Bambeke F; Michot JM; Van Eldere J; Tulkens PM
    Clin Microbiol Infect; 2005 Apr; 11(4):256-80. PubMed ID: 15760423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial clinical experience with clinafloxacin in the treatment of serious infections.
    Tack KJ; McGuire NM; Eiseman IA
    Drugs; 1995; 49 Suppl 2():488-91. PubMed ID: 8549411
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN
    J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract]   [Full Text] [Related]  

  • 27. ESGAB breakpoint determination: temafloxacin.
    Phillips I; Acar J; Baquero F; Bergan T; Forsgren A; Wiedemann B
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):991-2. PubMed ID: 1665417
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fluoroquinolones: importance, development of research, new drugs, questions for discussion].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(11):38-44. PubMed ID: 10079866
    [No Abstract]   [Full Text] [Related]  

  • 29. [Respiratory tract infections. Increasingly more established antibiotics fail].
    MMW Fortschr Med; 2002 Oct; 144(42):65. PubMed ID: 12534005
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals.
    Wallmann J
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():81-6. PubMed ID: 16530479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolones in animal health.
    Brown SA
    J Vet Pharmacol Ther; 1996 Feb; 19(1):1-14. PubMed ID: 8992019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximizing efficacy and reducing the emergence of resistance.
    Wise R
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():37-42. PubMed ID: 12702702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial resistance to antimicrobials.
    Ebrahim GJ
    J Trop Pediatr; 2010 Jun; 56(3):141-3. PubMed ID: 20504970
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro and in vivo antibacterial activities of CFC-222, a novel broad spectrum fluoroquinolone.
    Park KH; Cho IH; Lee JM; Kang JA; Kim YG; Hong KH; Kim JH; Nishino T
    Drugs; 1995; 49 Suppl 2():240-2. PubMed ID: 8549317
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity].
    Padeĭskaia EN
    Antibiot Khimioter; 2002; 47(1):26-35. PubMed ID: 12077937
    [No Abstract]   [Full Text] [Related]  

  • 36. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibiotics in primary care: focus on fluoroquinolones and other new and investigational antimicrobial agents.
    Pau AK; Slone RB
    Lippincotts Prim Care Pract; 1999; 3(1):39-54. PubMed ID: 10214201
    [No Abstract]   [Full Text] [Related]  

  • 38. [Review [new antimicrobial agent series XLI]: lomefloxacin].
    Soejima R; Matsumoto F
    Jpn J Antibiot; 1991 Oct; 44(10):1045-60. PubMed ID: 1662290
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluoroquinolones in the treatment of human infection: the role of temafloxacin.
    Am J Med; 1991 Dec; 91(6A):1S-171S. PubMed ID: 1662876
    [No Abstract]   [Full Text] [Related]  

  • 40. [New antibacterial agents].
    Vaara M; Saxén H
    Duodecim; 1999; 115(20):2259-64. PubMed ID: 11973930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.